LBJ49 (@LBJ49)

Kari Bundy - Health Activist r͏d͏n͏p͏S͏e͏o͏t͏o͏s͏l͏g͏c͏9͏5͏c͏f͏c͏a͏f͏h͏m͏0͏0͏l͏6͏9͏4͏9͏a͏a͏8͏h͏3͏0͏7͏h͏c͏c͏u͏l͏9͏l͏0͏1͏4͏3͏6͏7͏i͏m͏0͏c͏c͏2͏h͏g͏5͏t͏1͏ · 🚨 New paper: mRNA shots may trigger turbo cancer through 35 mechanisms, authors demand they be pulled from the market now Cancer in younger adults is rising, aggressive tumors are showing up with little warning, and U.S. cancer deaths have broken from the path they were on before the pandemic. A new analysis by Catanzaro, Hulscher, Stricker, Waselenko and McCullough says nucleoside-modified mRNA shots can start cancer, wake up old cancer, or make it grow much faster, a pattern they describe as turbo cancer. They list 35 ways these shots could promote cancer, grouped into four categories: turning on cancer-growth genes, raising mutation pressure and weakening DNA repair, disrupting how proteins work together, and speeding up cancer stem cells. Ongoing inflammation from the lipid particles and a weaker immune response add more strain. Their main idea is that these hits do not have to happen one after another. Several can land in the same person at the same time and shrink the usual years-long wait between hidden disease and a tumor that turns deadly fast. They gathered 333 published turbo cancer cases from 27 countries, covering lymphomas, leukemias, melanoma, breast, lung, brain tumors such as glioblastoma, sarcomas and pancreatic cancer. About 86% of the post-shot cases followed mRNA products, with Pfizer-BioNTech around 56%, Moderna 25%, and both products another 5%. The same warning signs keep showing up: cancer appearing quickly, growing very fast, old cancers coming back, and tumors near the injection site or nearby lymph nodes. Blood cancers are the largest group, while glioblastoma and pancreatic cancer appear most often in reports of sudden, severe worsening. The population numbers they cite are stark: • Their CDC WONDER analysis finds at least 119,130 extra U.S. cancer deaths, rising to 153,000–197,000 after adjustment • An independent look at the same records finds 154,330 extra deaths • SEER data show early-onset cancer jumping 6.4% in just two years from 2021 to 2023 • Brain and nervous-system tumors up 19.5% • Colorectal cancer up 19.4% • Sharp rises also in small-intestine, ovarian, stomach and female breast cancer • A South Korean study of 8.4 million people found higher one-year cancer risk across six types in vaccinated people • Italian data show a 23% higher risk of being hospitalized for cancer, with an adjusted hazard ratio of 1.23 The same shot technology is now being used as cancer treatment. The authors note that the lipid particles alone helped cancer spread in mice even with no mRNA inside them, and that encoded proteins can also show up in the heart and brain. BioNTech’s Phase 2 BNT122-01 trial of a personalized mRNA cancer shot in leftover colorectal cancer was stopped early because it was not working and deaths were higher in the treatment group, among patients who had already received earlier mRNA doses and still had remaining cancer. Thirty-five mechanisms, hundreds of documented cases across 27 countries, up to nearly 197,000 extra U.S. cancer deaths by their count, and a failed cancer trial… The authors call for these mRNA products to be taken off the market for routine prevention and stopped from expanding into cancer treatment. See less